HEMATOLOGY
May 17, 2016
Advances in the Treatment of Pediatric Acute Lymphoblastic Leukemia
Within the past few decades, there have been noteworthy advances in treatment of ALL in children.
January 20, 2016
Recommended Doses of Hydroxyurea Increase Sickle Cell Survival
December 14, 2015
Drug-Induced Bleeding
Drug-induced bleeding presents in many ways, including excessive bruising, nosebleeds, heavy menses, gastrointestinal bleeding, and rectal bleeding.
December 14, 2015
FDA Approves Three New Treatments for Multiple Myeloma
July 20, 2015
Options in the Management of Sickle Cell Disease
Iron chelation therapy and pain management are considered mainstay treatment options as the disease persists.
August 20, 2014
Breakthrough Therapy Approved for Leukemia and Lymphoma
January 22, 2014
Multiple Myeloma: An Overview of the Disease and Treatment Options
Multiple myeloma is the second most common hematologic malignancy diagnosed in the United States.
March 20, 2013
Venous Thromboembolism Prophylaxis in Multiple Myeloma Patients
Venous thromboembolism, which includes deep venous thrombosis and
pulmonary embolism, affects up to 20% of cancer patients.
January 23, 2013
Bone Marrow Modulators: Colony-Stimulating Factors and Erythrocyte-Stimulating Agents
Bone marrow modulators, such as colony-stimulating factors
and erythrocyte-stimulating agents, are used to treat toxicities of
cancer chemotherapy.
